Pharmaceuticals

Drug Development Drug Pricing Drug Safety Weight Loss Drugs Drug Approval Prescription Drugs Clinical Trials Drug Manufacturing Drug Regulation Diabetes Treatment

Cochrane Review Finds Low-Dose Colchicine Cuts Heart Attacks and Strokes in Cardiovascular Patients

Authors urge larger trials before routine use given modest absolute benefits in pooled results.

Novartis’ GanLum Tops 97% Cure in Phase III, Shows Transmission-Blocking Potential

Trump Quietly Pardons Rep. Harshbarger’s Husband in Health-Care Fraud Case

Pfizer Clinches $10 Billion Metsera Deal After Novo Nordisk Withdraws

Preliminary AHA Analysis Links Year-Long Melatonin Use to Higher Heart-Failure Risk

Organon Beats Q3 Estimates as Segment Performance Splits and Guidance Signals Confuse

Oral PCSK9 Pill Enlicitide Cuts LDL Up to 60% in Phase 3 Trial

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Repatha Cuts First Major Cardiac Events by 25% in At-Risk Adults in AHA Trial

CMS Chief Mehmet Oz Urges ‘Trump Babies’ Before 2026 at Oval Office Drug-Pricing Event

Abzena, Mabqi Forge Partnership to Link Antibody Discovery With Development and GMP Manufacturing

FDA Approves J&J’s Caplyta for Major Depressive Disorder

Insulet Beats Q3 Targets and Lifts 2025 Outlook on Surging Omnipod Sales

Cencora Commits Over $1 Billion to U.S. Drug Distribution Buildout Through 2030

Pfizer Tops Q3 Forecasts, Raises Profit Outlook

Eli Lilly Unveils $3 Billion Netherlands Plant for Oral GLP-1 Medicines as Stock Rises

Vertex Tops Q3 Estimates on CF Franchise as New Drugs Miss and Outlook Edges Higher

AbbVie Lifts 2025 Outlook and Dividend After Q3 Revenue Beat as Shares Fall

Eli Lilly Lifts 2025 Guidance After Tirzepatide Fuels Blowout Quarter

GOP Senators Press FDA Over Generic Abortion Pill Approval